To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
Biomimetism and Regenerative Medicine Team (BRM)
Invasion Mechanisms in Angiogenesis and Cancer team (IMAC)
Mechanisms of Angiogenesis in Biological Barriers team (MAB2)
highlight / actuality
We provides the proof of concept for an innovative multi-targeted anti-cancer strategy acting via the simultaneous degradation of a set of mRNA involved in angiogenesis and inflammation.
Top page
Thesis presented October 11, 2012 by Marie Bidart.
Thesis presented November 17, 2008 by Séverine Planel. PhD thesis available as a pdf file.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.
We provides the proof of concept for an innovative multi-targeted anti-cancer strategy acting via the simultaneous degradation of a set of mRNA involved in angiogenesis and inflammation.